Effect of Varicocele and Its Treatment on Testosterone in Hypogonadal Men with Varicocele: Review of the Literature
Adult
urinary tract
testicular
testosterone
varicocele
Journal
Balkan medical journal
ISSN: 2146-3131
Titre abrégé: Balkan Med J
Pays: Turkey
ID NLM: 101571817
Informations de publication
Date de publication:
10 04 2020
10 04 2020
Historique:
entrez:
20
2
2020
pubmed:
20
2
2020
medline:
21
4
2021
Statut:
ppublish
Résumé
Varicocele might cause deterioration in Leydig cell functions, and it is a significant risk factor for hypogonadism. Some controversial issues have been raised in the treatment of hypogonadal men with varicoceles. Symptomatic hypogonadal men with varicoceles have two options: testosterone replacement therapy or varicocele treatment. Both approaches have some advantages and disadvantages. This review summarizes the effect of varicoceles on total plasma testosterone level and addresses whether varicocele repair is effective to improve testosterone levels in hypogonadal men with varicoceles. Experience from large clinical studies in the literature suggests that varicocele repair may increase serum testosterone level in men with varicoceles and testosterone deficiency. Varicocele repair could be offered to men with clinically palpable varicocele and hypogonadism. As the treatment method, microsurgical varicocele repair could be preferred to provide the best improvement. Another advantage of varicocele repair for hypogonadism, instead of exogenous testosterone treatment, is its ability to preserve the fertility status in men who may desire a child in the future. However, further studies are required to clarify varicocel-related Leydig cell dysfunction and to advise hypogonadal patients about the sufficient effectiveness of varicocele repair.
Identifiants
pubmed: 32070086
doi: 10.4274/balkanmedj.galenos.2020.2020.1.85
pmc: PMC7161614
doi:
Substances chimiques
Testosterone
3XMK78S47O
Types de publication
Journal Article
Review
Langues
eng
Pagination
121-124Références
Asian J Androl. 2011 Mar;13(2):287-91
pubmed: 21076439
J Clin Endocrinol Metab. 1975 May;40(5):824-9
pubmed: 236323
Fertil Steril. 1978 Nov;30(5):577-85
pubmed: 720647
Fertil Steril. 2014 Jan;101(1):64-9
pubmed: 24094422
Asian J Androl. 2016 Mar-Apr;18(2):229-33
pubmed: 26806078
J Androl. 1984 May-Jun;5(3):163-70
pubmed: 6430851
J Urol. 2011 Feb;185(2):620-5
pubmed: 21168880
Asian J Androl. 2018 Oct 26;:
pubmed: 30381578
Urology. 2008 Nov;72(5):1179-84
pubmed: 18514768
Int J Urol. 2012 Feb;19(2):149-54
pubmed: 22059526
Fertil Steril. 2011 Dec;96(6):1288-93
pubmed: 22130099
Urology. 2013 Jun;81(6):1213-7
pubmed: 23561709
BJU Int. 1999 Dec;84(9):1046-9
pubmed: 10571633
J Androl. 2009 Jan-Feb;30(1):33-40
pubmed: 18772487
J Sex Med. 2011 Mar;8(3):885-93
pubmed: 20722780
Urology. 1997 Aug;50(2):257-9
pubmed: 9255298
Biol Reprod. 1987 May;36(4):933-7
pubmed: 3593858
Urology. 2018 Jul;117:64-69
pubmed: 29649543
Int J Endocrinol. 2011;2011:916380
pubmed: 22190930
Fertil Steril. 2018 Dec;110(7):1239-1245
pubmed: 30503112
Urology. 2014 Nov;84(5):1081-7
pubmed: 25214202
Urol Clin North Am. 2016 May;43(2):223-32
pubmed: 27132580
Andrologia. 2017 Dec;49(10):
pubmed: 28378913
BJU Int. 2011 Nov;108(9):1480-4
pubmed: 21435152